American Diabetes Association “Standards of Medical Care in Diabetes” is based on a complete review of the relevant literature by a diverse group of highly trained clinicians and researchers. After weighing the quality of evidence, from rigorous double-blind clinical trials to expert opinion, recommendations are drafted, reviewed, and submitted for approval to the American Diabetes Association Executive Committee. To see the 2021 Standards, please visit professional.diabetes.org/SOC.

The 68th annual American Diabetes Association Advanced Postgraduate Course will be held virtually from 3 February to 7 February 2021. Join your colleagues and diabetes experts for presentations and discussions on cutting-edge clinical research in diabetes. The course will cover the latest clinical research translated into evidence-based treatment strategies to improve outcomes in your patients with diabetes. All prerecorded sessions will be released during the original scheduled times over the 5-day meeting, and all registered attendees will receive unlimited access to all virtual content for 30 days after the meeting. Registration for the 68th Advanced Postgraduate Course is now open. For more information, please visit professional.diabetes.org/ce.

In a series of short videos now available on the Clinical Diabetes website, an expert panel moderated by John Anderson, MD, discusses approaches to optimizing basal insulin initiation and treatment in people with type 2 diabetes, including those at high risk such as individuals with renal impairment and older adults, with a focus on reaching A1C goals while mitigating the risk for hypoglycemia. An executive summary and videos of the full panel can be found at clinical.diabetesjournals.org/content/basal-insulin-videos.

The 35th Annual Clinical Conference on Diabetes will be held in Ponte Vedra Beach, Florida, on 27–30 May 2021 at the Sawgrass Marriott Golf Resort & Spa. The ADA Clinical Conference is designed specifically for primary care physicians, physician assistants, nurse practitioners, pharmacists, nurses, psychologists, dietitians, certified diabetes educators, and other health care professionals who care for patients with diabetes or those at risk for diabetes and who manage diabetes-related complications. For registration details and more information, please visit professional.diabetes.org/ce.

“Diabetes and COVID-19” is an online collection of articles on the Diabetes Care website featuring the latest studies, clinical observations, and commentaries on COVID-19 with specific relation to patients with diabetes. Topics include management of diabetes and its complications during the pandemic, blood glucose control and remote glucose monitoring, and outcomes in patients with hyperglycemia, cardiovascular risk, and obesity. This web page is updated regularly as relevant Diabetes Care articles are published online ahead of print. To access the collection, visit care.diabetesjournals.org/collection/diabetes-and-COVID19.

This special three-episode series (made possible by an independent educational grant from Sanofi) explores the multiple facets of therapeutic inertia. Drs. Neil Skolnik and John Russell present and discuss the latest clinically relevant articles and information related to the impact of therapeutic inertia, the importance of getting to goal, and the benefits of simultaneous intensification versus sequential treat-to-fail approaches for patients with diabetes. To listen to the complete series, visit diabetesjournals.org/content/therapeutic-inertia-podcasts.

The American Diabetes Association is dedicated to ensuring that you stay informed of the latest COVID-19 research and guidelines. Our new online page for diabetes professionals includes essential resources and information—including webinars, patient guidance, relevant news articles, a discussion forum, and more. Follow updates and join the conversation at professional.diabetes.org/content-page/covid-19.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.